Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lili Cao, Xiaofang Che, Xueshan Qiu, Zhi Li, Bowen Yang, Shuo Wang, Kezuo Hou, Yibo Fan, Xiujuan Qu & Yunpeng Liu. (2019) M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer. Cancer Management and Research 11, pages 6125-6138.
Read now
Read now
Articles from other publishers (58)
Jian Luo, Wanying Xiao, Fengyang Hua, Yanqing Cao, Dongxia Wang & Xicheng Wang. (2023) Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-analysis. BMC Cancer 23:1.
Crossref
Crossref
Yao Lin, Yuxin Lin, Xiaoping Zhong, Qingshan Chen, Shijie Tang & Jiasheng Chen. (2023) A case report and literature review on reactive cutaneous capillary endothelial proliferation induced by camrelizumab in a nasopharyngeal carcinoma patient. Frontiers in Oncology 13.
Crossref
Crossref
Pui Yan Siak, Win Sen Heng, Sharon Siew Hoon Teoh, Yu Yu Lwin & Shiau-Chuen Cheah. (2023) Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect. Journal of Translational Medicine 21:1.
Crossref
Crossref
Yang Liu, Ziou Du, Shiyu Song & Junlin Yi. (2023) Progress in the comprehensive treatment of nasopharyngeal carcinoma: a review for risk-stratified management strategies. Holistic Integrative Oncology 2:1.
Crossref
Crossref
Hendrik Setia Budi & Bagher Farhood. (2023) Targeting oral tumor microenvironment for effective therapy. Cancer Cell International 23:1.
Crossref
Crossref
Yuankai Shi, Xintian Qin, Xingchen Peng, Aiping Zeng, Jingao Li, Chuanben Chen, Sufang Qiu, Suming Pan, Yulong Zheng, Jing Cai, Xiaopin Chen, Shenhong Qu, Lizhu Lin, Jianli Huang, Hui Wu, Ying Lu, Wei Wang, Changlu Hu, Xia He, Zhonghua Yu, Xiaojian Liu, Bo Xie, Anwen Liu, Guangyuan Hu, Shanghua Jing, Qingyuan Zhang, Renhua Guo, Qi Li, Jinsheng Hong, Feng Jin, Juan Meng, Jianhua Shi, Peiguo Wang, Jiuwei Cui, Kunyu Yang, Xuebang Zhang, Xiaojiang Li, Liangfang Shen, Yuxiang He, Limin Zhai, Xiuhua Sun, Junyou Ge, Yan Qing & Dekang Zong. (2023) Efficacy and safety of KL-A167 in previously treated recurrent or metastatic nasopharyngeal carcinoma: a multicenter, single-arm, phase 2 study. The Lancet Regional Health - Western Pacific 31, pages 100617.
Crossref
Crossref
Song Xue, Ge Song, Yingming Zhu, Nianping Zhang & Ying Tan. (2022) The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A meta-analysis. Oral Oncology 135, pages 106231.
Crossref
Crossref
Fengge Zhou, Gulidanna Shayan, Shiran Sun, Xiaodong Huang, Xuesong Chen, Kai Wang, Yuan Qu, Runye Wu, Ye Zhang, Qingfeng Liu, Jianghu Zhang, Jingwei Luo, Xinqi Shi, Yang Liu, Bin Liang, Ye-Xiong Li, Jingbo Wang & Junlin Yi. (2022) Spatial architecture of regulatory T-cells correlates with disease progression in patients with nasopharyngeal cancer. Frontiers in Immunology 13.
Crossref
Crossref
Liyan Qu, Jiakang Jin, Jianan Lou, Chao Qian, Jinti Lin, Ankai Xu, Bing Liu, Man Zhang, Huimin Tao & Wei Yu. (2022) The nuclear transportation of PD-L1 and the function in tumor immunity and progression. Cancer Immunology, Immunotherapy 71:10, pages 2313-2323.
Crossref
Crossref
Siqing Jiang, Xin Li, Lihua Huang, Zhensheng Xu & Jinguan Lin. (2022) Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer. Frontiers in Immunology 13.
Crossref
Crossref
Jianyun Jiang & Hongmei Ying. (2022) Revealing the crosstalk between nasopharyngeal carcinoma and immune cells in the tumor microenvironment. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Crossref
Sumiyo Saburi, Takahiro Tsujikawa, Aya Miyagawa-Hayashino, Junichi Mitsuda, Kanako Yoshimura, Alisa Kimura, Hiroki Morimoto, Gaku Ohmura, Akihito Arai, Hiroshi Ogi, Eiichi Konishi, Kyoko Itoh, Kiminori Sugino & Shigeru Hirano. (2022) Spatially resolved immune microenvironmental profiling for follicular thyroid carcinoma with minimal capsular invasion. Modern Pathology 35:6, pages 721-727.
Crossref
Crossref
Tao Ren, Xian-Yu Bai, Meng-Zhe Yang, Ning Xu, Xing-Zhe Guo, Liu-Jie Qin, Zhi-Lin Huang, Qiong-Yao Zhong, Yuan-Jiao Huang, Wen-Zhen Lin, Ai-Jun Jiao & Bei-Bei Zhang. (2022) Gambogic acid suppresses nasopharyngeal carcinoma via rewiring molecular network of cancer malignancy and immunosurveillance. Biomedicine & Pharmacotherapy 150, pages 113012.
Crossref
Crossref
Zhi Yi Su, Pui Yan Siak, Chee-Onn Leong & Shiau-Chuen Cheah. (2022) Nasopharyngeal Carcinoma and Its Microenvironment: Past, Current, and Future Perspectives. Frontiers in Oncology 12.
Crossref
Crossref
Xiaoyu Li, Xingchen Peng, Sha Zhao, Hong Zhang, Yong Jiang, Fei Liu & Ping Ai. (2022) Combined Association of Tumoral PD-L1 Expression and Pretreatment Presence of Epstein-Barr Virus DNA With Risk Stratification and Prognosis of Patients With Nasopharyngeal Carcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Weixing Liu, Gui Chen, Chunyi Zhang, Xiao Liao, Junyang Xie, Tianhao Liang, Wenjing Liao, Lijuan Song & Xiaowen Zhang. (2021) Prognostic significance of tumor-infiltrating lymphocytes and macrophages in nasopharyngeal carcinoma: a systematic review and meta-analysis. European Archives of Oto-Rhino-Laryngology 279:1, pages 25-35.
Crossref
Crossref
Jun Ma & Yu-Pei Chen. 2022.
Ramon Yarza, Mateo Bover, Maria Teresa Agulló-Ortuño & Lara Carmen Iglesias-Docampo. (2021) Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Crossref
Qingxu Song, Pengxiang Chen, Xin Chen, Cong Sun, Jianbo Wang, Bingxu Tan, Hong Liu & Yufeng Cheng. (2021) Dynamic Change of Amide Proton Transfer Imaging in Irradiated Nasopharyngeal Carcinoma and Related Histopathological Mechanism. Molecular Imaging and Biology 23:6, pages 846-853.
Crossref
Crossref
Xiaowan Tang, Weijun Zhou, Danjiang Huang, Lili Chen & Guangwen Zhang. (2021) Anti-PD-1 Therapy—A Potential Treatment for Myocardial Metastasis From Nasopharyngeal Carcinoma: A Case Report. Frontiers in Immunology 12.
Crossref
Crossref
Kenneth C. W. Wong, Edwin P. Hui, Kwok-Wai Lo, Wai Kei Jacky Lam, David Johnson, Lili Li, Qian Tao, Kwan Chee Allen Chan, Ka-Fai To, Ann D. King, Brigette B. Y. Ma & Anthony T. C. Chan. (2021) Nasopharyngeal carcinoma: an evolving paradigm. Nature Reviews Clinical Oncology 18:11, pages 679-695.
Crossref
Crossref
Ashley R. Hoover, Kaili Liu, Trisha I. Valerio, Min Li, Priyabrata Mukherjee & Wei R. Chen. (2021) Nano-ablative immunotherapy for cancer treatment. Nanophotonics 10:12, pages 3247-3266.
Crossref
Crossref
Salvatore Panza, Rocco Malivindi, Amanda Caruso, Umberto Russo, Francesca Giordano, Balázs Győrffy, Luca Gelsomino, Francesca De Amicis, Ines Barone, Francesca Luisa Conforti, Cinzia Giordano, Daniela Bonofiglio, Stefania Catalano & Sebastiano Andò. (2021) Novel Insights into the Antagonistic Effects of Losartan against Angiotensin II/AGTR1 Signaling in Glioblastoma Cells. Cancers 13:18, pages 4555.
Crossref
Crossref
Tingting Huang, Zhe Zhang & Xiaoying Zhou. 2021. Pharynx - Diagnosis and Treatment. Pharynx - Diagnosis and Treatment.
Fan Luo, Jiaxin Cao, Feiteng Lu, Kangmei Zeng, Wenjuan Ma, Yan Huang, Li Zhang & Hongyun Zhao. (2021) Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes. Cancer Cell International 21:1.
Crossref
Crossref
J. Boustani, A. Ruffier, A. Moya-Plana, Y. Tao, F. Nguyen, C. Even, C. Berthold, O. Casiraghi, S. Temam & P. Blanchard. (2020) Long-term outcomes and safety after reirradiation in locally recurrent nasopharyngeal carcinoma in a non-endemic area. Strahlentherapie und Onkologie 197:3, pages 188-197.
Crossref
Crossref
David Johnson & Brigette B.Y. Ma. (2021) Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma. Oral Oncology 113, pages 105127.
Crossref
Crossref
Ya Cao, Longlong Xie, Feng Shi, Min Tang, Yueshuo Li, Jianmin Hu, Lin Zhao, Luqing Zhao, Xinfang Yu, Xiangjian Luo, Weihua Liao & Ann M. Bode. (2021) Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Birhanu Aberha Berele, Yuxiang Cai & Guifang Yang. (2021) Prognostic Value of Tumor Infiltrating Lymphocytes in Nasopharyngeal Carcinoma Patients: Meta-Analysis. Technology in Cancer Research & Treatment 20, pages 153303382110342.
Crossref
Crossref
Xiaoshuang Niu & Yungan Tao. 2021. Critical Issues in Head and Neck Oncology. Critical Issues in Head and Neck Oncology
327
335
.
Nasser Al-Rajhi, Hussein Soudy, Shoaib A. Ahmed, Tusneem Elhassan, Shamayel F. Mohammed, Hatim A. Khoja & Hazem Ghebeh. (2020) CD3+T-lymphocyte infiltration is an independent prognostic factor for advanced nasopharyngeal carcinoma. BMC Cancer 20:1.
Crossref
Crossref
Qian Zhu, Qiu-Zhong Pan, Ai-Lin Zhong, Hao Hu, Jing-Jing Zhao, Yan Tang, Wan-Ming Hu, Min Li, De-Sheng Weng, Ming-Yuan Chen, Gang Ma & Jian-Chuan Xia. (2020) Annexin A3 upregulates the infiltrated neutrophil-lymphocyte ratio to remodel the immune microenvironment in hepatocellular carcinoma. International Immunopharmacology 89, pages 107139.
Crossref
Crossref
Michael Wotman, Saori W. HermanPeter Costantino & Tristan Tham. (2020) The Prognostic Role of Programmed Death‐Ligand 1 in Nasopharyngeal Carcinoma. The Laryngoscope 130:11, pages 2598-2606.
Crossref
Crossref
Takahiro Tsujikawa, Junichi Mitsuda, Hiroshi Ogi, Aya Miyagawa‐Hayashino, Eiichi Konishi, Kyoko Itoh & Shigeru Hirano. (2020) Prognostic significance of spatial immune profiles in human solid cancers. Cancer Science 111:10, pages 3426-3434.
Crossref
Crossref
Hanghang Li, Xiang Chen, Wenjing Zeng, Weibing Zhou, Qin Zhou, Zhan Wang, Wuzhong Jiang, Bowen Xie & Lun-Quan Sun. (2020) Radiation-Enhanced Expression of CCL22 in Nasopharyngeal Carcinoma is Associated With CCR4+ CD8 T Cell Recruitment. International Journal of Radiation Oncology*Biology*Physics 108:1, pages 126-139.
Crossref
Crossref
Chengcheng Hao, Gang Chen, Huishan Zhao, Yan Li, Jianxin Chen, Hongmei Zhang, Shan Li, Yuze Zhao, Feng Chen, Wenbin Li & Wen G. Jiang. (2020) PD-L1 Expression in Glioblastoma, the Clinical and Prognostic Significance: A Systematic Literature Review and Meta-Analysis. Frontiers in Oncology 10.
Crossref
Crossref
Brigette B.Y. Ma, Yu-Pei Chen, Edwin P. Hui, Xu Liu, Allen K.C. Chan, Anthony T.C. Chan & Jun Ma. (2020) Recent Advances in the Development of Biomarkers and Chemoradiotherapeutic Approaches for Nasopharyngeal Carcinoma. American Society of Clinical Oncology Educational Book:40, pages 270-280.
Crossref
Crossref
Wai Nam Liu, Shin Yie Fong, Wilson Wei Sheng Tan, Sue Yee Tan, Min Liu, Jia Ying Cheng, Sherlly Lim, Lisda Suteja, Edwin Kunxiang Huang, Jerry Kok Yen Chan, Narayanan Gopalakrishna Iyer, Joe Poh Sheng Yeong, Darren Wan-Teck Lim & Qingfeng Chen. (2020) Establishment and Characterization of Humanized Mouse NPC-PDX Model for Testing Immunotherapy. Cancers 12:4, pages 1025.
Crossref
Crossref
Sai-Lan Liu, Li-Juan Bian, Ze-Xian Liu, Qiu-Yan Chen, Xue-Song Sun, Rui Sun, Dong-Hua Luo, Xiao-Yun Li, Bei-Bei Xiao, Jin-Jie Yan, Zi-Jian Lu, Shu-Mei Yan, Li Yuan, Lin-Quan Tang, Jian-Ming Li & Hai-Qiang Mai. (2020) Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma. Journal for ImmunoTherapy of Cancer 8:1, pages e000205.
Crossref
Crossref
Soehartati A. Gondhowiardjo, Handoko, Marlinda Adham, Lisnawati Rachmadi, Henry Kodrat, Demak Lumban Tobing, I. Made Haryoga, Agustinus Gatot Dwiyono, Yoseph Adi Kristian & Tiara Bunga Mayang Permata. (2020) Tumor microenvironment predicts local tumor extensiveness in PD-L1 positive nasopharyngeal cancer. PLOS ONE 15:3, pages e0230449.
Crossref
Crossref
Xin-Lin He, Ying Zhou, Huan-Zi Lu, Qun-Xing Li & Zhi Wang. (2020) Prognostic value of VISTA in solid tumours: a systematic review and meta-analysis. Scientific Reports 10:1.
Crossref
Crossref
Qian Zhu, Ai-Lin Zhong, Hao Hu, Jing-Jing Zhao, De-Sheng Weng, Yan Tang, Qiu-Zhong Pan, Zi-Qi Zhou, Meng-Jia Song, Jie-Ying Yang, Jun-Yi He, Yuan Liu, Min Li, Wan-Ming Hu, Chao-Pin Yang, Tong Xiang, Ming-Yuan Chen, Gang Ma, Ling Guo & Jian-Chuan Xia. (2020) Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma. Journal of Hematology & Oncology 13:1.
Crossref
Crossref
Hayriye Sahinli, Nalan Akyürek, Mukaddes Yılmaz, Olcay Kandemir, AyşeOcak Duran, Sezer Kulaçoǧlu, Gökhan Uçar, Elif Acar, Ahmet Özet, ÖBerna Ç. Öksüzoǧlu & NuriyeY Özdemir. (2020) Good prognostic factor in patients with nonmetastatic nasopharyngeal carcinoma: Programmed death ligand-1 expression in tumor cells. Journal of Cancer Research and Therapeutics 0:0, pages 0.
Crossref
Crossref
Hayriye Sahinli, Nalan Akyürek, Mukaddes Yılmaz, Olcay Kandemir, AyşeOcak Duran, Sezer Kulaçoğlu, Gökhan Uçar, Elif Acar, Ahmet Özet, Mahmut Gümüş, ÖBerna Ç. Öksüzoğlu & NuriyeY Özdemir. (2020) PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma. Indian Journal of Cancer 0:0, pages 0.
Crossref
Crossref
Ya-Qin Wang, Yu Zhang, Wei Jiang, Yu-Pei Chen, Shuo-Yu Xu, Na Liu, Yin Zhao, Li Li, Yuan Lei, Xiao-Hong Hong, Ye-Lin Liang, Jun-Yan Li, Lu-Lu Zhang, Jing-Ping Yun, Ying Sun, Ying-Qin Li & Jun Ma. (2019) Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Yu-Li Chen, Han-Wei Lin, Chung-Liang Chien, Yen-Ling Lai, Wei-Zen Sun, Chi-An Chen & Wen-Fang Cheng. (2019) BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Jia-Wei Lv, Jun-Yan Li, Lin-Na Luo, Zi-Xian Wang & Yu-Pei Chen. (2019) Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Zi-Lu Huang, Shan Liu, Guan-Nan Wang, Shuo-Han Zheng, Shi-Rong Ding, Ya-lan Tao, Chen Chen, Song-Ran Liu, Xin Yang, Hui Chang, Xiao-Hui Wang & Yun-Fei Xia. (2019) The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis. Cancer Cell International 19:1.
Crossref
Crossref
Chang-Ying Guo, Qian Zhu, Fang-Fang Tou, Xiao-Ming Wen, Yu-Kang Kuang & Hao Hu. (2019) The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma. BMC Cancer 19:1.
Crossref
Crossref
Christoph Minichsdorfer, Felicitas Oberndorfer, Christoph Krall, Gabriela Kornek, Leonhard Müllauer, Christina Wagner & Thorsten Fuereder. (2019) PD-L1 Expression on Tumor Cells Is Associated With a Poor Outcome in a Cohort of Caucasian Nasopharyngeal Carcinoma Patients. Frontiers in Oncology 9.
Crossref
Crossref
Xiaofeng Liu, Chunguang Shan, Yingluan Song & Juan Du. (2019) Prognostic Value of Programmed Cell Death Ligand-1 Expression in Nasopharyngeal Carcinoma: A Meta-Analysis of 1,315 Patients. Frontiers in Oncology 9.
Crossref
Crossref
Yu-Pei Chen, Anthony T C Chan, Quynh-Thu Le, Pierre Blanchard, Ying Sun & Jun Ma. (2019) Nasopharyngeal carcinoma. The Lancet 394:10192, pages 64-80.
Crossref
Crossref
Yi-Qun Jia, Bo Yang, Li-Ling Wen, Wen-Xin Mu, Zhi Wang & Bin Cheng. (2019) Prognostic value of immune checkpoint molecules in head and neck cancer: a meta-analysis. Aging 11:2, pages 501-522.
Crossref
Crossref
Yu-Jen Liu, Ngan-Ming Tsang, Chuen Hsueh, Chi-Ju Yeh, Shir-Hwa Ueng, Tong-Hong Wang & Wen-Yu Chuang. (2018) Low PD-L1 Expression Strongly Correlates with Local Recurrence in Epstein-Barr Virus-Positive Nasopharyngeal Carcinoma after Radiation-Based Therapy. Cancers 10:10, pages 374.
Crossref
Crossref
Takeharu Ono, Koichi Azuma, Akihiko Kawahara, Tetsuro Sasada, Norikazu Matsuo, Tatsuyuki Kakuma, Hiroyuki Kamimura, Ririko Maeda, Chikayuki Hattori, Kotaro On, Kei Nagata, Fumihiko Sato, Shun-ich Chitose, Buichiro Shin, Takeichiro Aso, Jun Akiba & Hirohito Umeno. (2018) Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment. Head & Neck 40:9, pages 2007-2019.
Crossref
Crossref
Mei Yi, Jing Cai, Junjun Li, Shengnan Chen, Zhaoyang Zeng, Qian Peng, Yuanyuan Ban, Ying Zhou, Xiaoling Li, Wei Xiong, Guiyuan Li & Bo Xiang. (2018) Rediscovery of NF‐κB signaling in nasopharyngeal carcinoma: How genetic defects of NF‐κB pathway interplay with EBV in driving oncogenesis?. Journal of Cellular Physiology 233:8, pages 5537-5549.
Crossref
Crossref
Brigette B.Y. MaWan-Teck LimBoon-Cher GohEdwin P. HuiKwok-Wai LoAdam PettingerNathan R. FosterJonathan W. RiessMark AgulnikAlex Y.C. ChangAkhil ChopraJulie A. KishChristine H. ChungDouglas R. AdkinsKevin J. CullenBarbara J. GitlitzDean W. LimKa-Fai ToK.C. Allen ChanY.M. Dennis LoAnn D. KingCharles ErlichmanJun YinBrian A. CostelloAnthony T.C. Chan. (2018) Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742). Journal of Clinical Oncology 36:14, pages 1412-1418.
Crossref
Crossref
Marie-Emilie Dourthe, Stéphanie Bolle, Stéphane Temam, Anais Jouin, Line Claude, Yves Reguerre, Anne-Sophie Defachelles, Daniel Orbach & Brice Fresneau. (2018) Childhood Nasopharyngeal Carcinoma: State-of-the-Art, and Questions for the Future. Journal of Pediatric Hematology/Oncology 40:2, pages 85-92.
Crossref
Crossref